tiprankstipranks
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market
Holding MLTX?
Track your performance easily

MoonLake Immunotherapeutics (MLTX) Financial Statements

297 Followers

MoonLake Immunotherapeutics Financial Overview

MoonLake Immunotherapeutics's market cap is currently ―. The company's EPS TTM is $-1.291; its P/E ratio is -38.59; MoonLake Immunotherapeutics is scheduled to report earnings on March 24, 2025, and the estimated EPS forecast is $-0.60. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -36.02M$ -24.68M$ -13.91M-$ -12.98M
EBITDA$ -35.99M$ -24.65M$ -13.88M-$ -12.97M
Net Income Common Stockholders$ -35.39M$ -24.27M$ -13.67M$ -5.24M$ -11.62M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 493.92M$ 519.80M$ 547.05M$ 511.01M$ 495.98M
Total Assets$ 518.21M$ 544.88M$ 564.12M$ 526.54M$ 500.22M
Total Debt$ 3.38M$ 3.34M$ 3.66M$ 3.70M$ 169.42K
Net Debt$ -490.54M$ -516.46M$ -543.39M$ -507.31M$ -495.81M
Total Liabilities$ 22.71M$ 14.85M$ 11.73M$ 13.05M$ 10.58M
Stockholders Equity$ 488.20M$ 520.66M$ 542.55M$ 495.68M$ 424.93M
Cash Flow-
Free Cash Flow$ -25.41M$ -27.89M$ -15.16M-$ -9.25M
Operating Cash Flow$ -25.27M$ -27.89M$ -14.95M$ -12.34M$ -9.25M
Investing Cash Flow$ 58.28M$ -87.74M$ -28.80M$ 116.87M$ -174.38M
Financing Cash Flow$ 183.10K-$ 50.98M$ 28.42M-
Currency in USD

MoonLake Immunotherapeutics Earnings and Revenue History

MoonLake Immunotherapeutics Debt to Assets

MoonLake Immunotherapeutics Cash Flow

MoonLake Immunotherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis